<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: interleukin</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Markers warn of progressive kidney problems after heart surgery</title>
   	 <description>Blood and urine markers can indicate which patients with an abrupt kidney injury following heart surgery will experience progressive kidney problems, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). Testing for these markers soon after surgery could help doctors protect the health of patients' kidneys.</description>
	  <link>http://medicalxpress.com/news/2012-03-markers-kidney-problems-heart-surgery.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 01 Mar 2012 17:28:15 EST</pubDate>
	 <guid isPermaLink="false">news249845255</guid>
	 
</item>
<item>
     <title>Study explains high platelets in ovarian cancer patients, survival reduced</title>
   	 <description>Highly elevated platelet levels fuel tumor growth and reduce the survival of ovarian cancer patients, an international team of researchers led by scientists at The University of Texas MD Anderson Cancer center reports in the New England Journal of Medicine.</description>
	  <link>http://medicalxpress.com/news/2012-02-high-platelets-ovarian-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 15 Feb 2012 17:00:10 EST</pubDate>
	 <guid isPermaLink="false">news248544367</guid>
	 
</item>
<item>
     <title>Drug halts organ damage in inflammatory genetic disorder</title>
   	 <description>A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease (NOMID). This rare and debilitating genetic disorder causes persistent inflammation and ongoing tissue damage. The research was performed by scientists at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health.</description>
	  <link>http://medicalxpress.com/news/2012-02-drug-halts-inflammatory-genetic-disorder.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Fri, 10 Feb 2012 12:55:00 EST</pubDate>
	 <guid isPermaLink="false">news248100889</guid>
	 
</item>
<item>
     <title>Mutated Kras spins a molecular loop that launches pancreatic cancer</title>
   	 <description>Scientists have connected two signature characteristics of pancreatic cancer, identifying a self-perpetuating &quot;vicious cycle&quot; of molecular activity and a new potential target for drugs to treat one of the most lehal forms of cancer.</description>
	  <link>http://medicalxpress.com/news/2012-01-mutated-kras-molecular-loop-pancreatic.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 26 Jan 2012 10:29:06 EST</pubDate>
	 <guid isPermaLink="false">news246796113</guid>
	 
</item>
<item>
     <title>Inflammation may link obesity and adverse pregnancy outcomes</title>
   	 <description>A number of different immunological mechanisms ensure the successful establishment and maintenance of pregnancy. Imbalance in these mechanisms is associated with adverse pregnancy outcomes. In a review published in Advances in Neuroimmune Biology, researchers from the Institute of Life Science, College of Medicine at Swansea University in the UK examine the impact of maternal obesity on the inflammatory responses in tissues of both the mother and the child.</description>
	  <link>http://medicalxpress.com/news/2012-01-inflammation-link-obesity-adverse-pregnancy.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 10 Jan 2012 15:43:22 EST</pubDate>
	 <guid isPermaLink="false">news245432586</guid>
	 
</item>
<item>
     <title>Clinical trial demonstrates that rilonacept significantly reduces gout flares</title>
   	 <description>A phase II clinical trial found that rilonacept, an inhibitor of the protein interleukin-1 (IL-1), significantly reduced acute gout flares that occur when initiating uric acid-lowering therapy. Results of the trial&amp;#151;the first placebo-controlled study investigating IL-1 targeted therapy in prevention of gout flares&amp;#151;show rilonacept to be generally well tolerated with no serious infections or treatment-related serious adverse events reported. Full findings are published in Arthritis &amp; Rheumatism, a journal of the American College of Rheumatology (ACR).</description>
	  <link>http://medicalxpress.com/news/2012-01-clinical-trial-rilonacept-significantly-gout.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 05 Jan 2012 04:50:01 EST</pubDate>
	 <guid isPermaLink="false">news244959263</guid>
	 
</item>
<item>
     <title>New study shows how B cells may generate antibodies after vaccination</title>
   	 <description>Steve Reiner, MD, professor of Medicine, and Burton Barnett, a doctoral student in the Reiner lab at the Perelman School of Medicine at the University of Pennsylvania, have shown how immune cells, called B lymphocytes, are able to produce daughter cells that are not equal, a finding that might explain how lifelong antibodies are made after vaccination.</description>
	  <link>http://medicalxpress.com/news/2011-12-cells-antibodies-vaccination.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 15 Dec 2011 14:00:13 EST</pubDate>
	 <guid isPermaLink="false">news243178420</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/9-newstudyshow.jpg" width="90" height="90" />
</item>
<item>
     <title>Research describes advantages of new vaccine adjuvant</title>
   	 <description>New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest it could be useful for enhancing protection against a number of different infections. This new data will be published in the January 2012 issue of the journal Nature Immunology (Vol. 13, pp. 44-50). The paper, &quot;iNKT cells direct B cell responses to cognate lipid antigen in an interleukin 21-dependent manner,&quot; is now available through Advance Online Publication (AOP) on Nature Immunology's website.</description>
	  <link>http://medicalxpress.com/news/2011-12-advantages-vaccine-adjuvant.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 12 Dec 2011 12:00:04 EST</pubDate>
	 <guid isPermaLink="false">news242912269</guid>
	 
</item>
<item>
     <title>Study discovers new targets for treating inflammatory, autoimmune diseases</title>
   	 <description>Researchers have discovered a cellular pathway that promotes inflammation in diseases like asthma, rheumatoid arthritis, psoriasis, inflammatory bowel disease, and multiple sclerosis. Understanding the details of this pathway may provide opportunities for tailored treatments of inflammatory and autoimmune diseases.</description>
	  <link>http://medicalxpress.com/news/2011-10-inflammatory-autoimmune-diseases.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Fri, 07 Oct 2011 12:10:45 EST</pubDate>
	 <guid isPermaLink="false">news237208178</guid>
	 
</item>
<item>
     <title>Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients</title>
   	 <description>Melanoma of the eye (ocular or uveal melanoma) frequently spreads to the liver and, once this has happened, there is no effective treatment and patients die within an average of two to four months. Only about one in ten patients live for a year. Now, final results from a phase III study have demonstrated that a new treatment significantly extends the time patients can live without the disease progressing.</description>
	  <link>http://medicalxpress.com/news/2011-09-infusing-chemotherapy-liver-extra-months.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 23 Sep 2011 18:48:47 EST</pubDate>
	 <guid isPermaLink="false">news236022479</guid>
	 
</item>
<item>
     <title>Obese dieters' brain chemistry works against their weight-loss efforts</title>
   	 <description>If you've been trying to lose weight and suspect your body's working against you, you may be right, according to a University of Illinois study published in Obesity.</description>
	  <link>http://medicalxpress.com/news/2011-06-obese-dieters-brain-chemistry-weight-loss.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 23 Jun 2011 12:05:33 EST</pubDate>
	 <guid isPermaLink="false">news228049516</guid>
	 
</item>
<item>
     <title>Transcription factor regulates protein that dampens immune responses</title>
   	 <description>Interleukin-10 (IL-10) is an anti-inflammatory cytokine protein that reduces immune responses and staves off autoimmune disease. Now, a research team led by Masato Kubo at the RIKEN Research Center for Allergy and Immunology, Yokohama, has identified a transcription factor called E4 promoter-binding protein (E4BP4) that is responsible for driving the expression of IL-10 in multiple types of immune cells.</description>
	  <link>http://medicalxpress.com/news/2011-06-transcription-factor-protein-dampens-immune.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 17 Jun 2011 13:03:49 EST</pubDate>
	 <guid isPermaLink="false">news227534618</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/preventingov.jpg" width="90" height="85" />
</item>
<item>
     <title>Researchers find potential new way to fight sepsis</title>
   	 <description>By digging a little deeper, researchers may have found a potential target for reversing the deadly blood infection sepsis.</description>
	  <link>http://medicalxpress.com/news/2011-06-potential-sepsis.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 10 Jun 2011 11:24:41 EST</pubDate>
	 <guid isPermaLink="false">news226923855</guid>
	 
</item>
<item>
     <title>Gene therapy reverses type 1 diabetes in mice</title>
   	 <description>An experimental cure for Type 1 diabetes has a nearly 80 percent success rate in curing diabetic mice. The results, to be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston, offer possible hope of curing a disease that affects 3 million Americans.</description>
	  <link>http://medicalxpress.com/news/2011-06-gene-therapy-reverses-diabetes-mice.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 06 Jun 2011 09:53:19 EST</pubDate>
	 <guid isPermaLink="false">news226572254</guid>
	 
</item>


</channel>
</rss>
